HealthMore in Health→
STAT’s ‘Readout LOUD’ Spotlights Biotech Finance, Obesity Drug Competition, and FDA Friction
Key Takeaways
- STAT’s latest podcast episode centers on Seaport Therapeutics’ IPO, obesity pill competition, and Marty Makary’s troubles.
- The lineup links biotech finance, a major drug market, and FDA politics.
- The episode reflects how commercial, regulatory, and political pressures are converging in health care.
DE
DT Editorial Team··via statnews.com
